Advertisement

Molecular aspects of the interaction of (+)-CC-1065 with DNA

  • Laurence H. Hurley
  • Patricia H. Draves
Chapter
Part of the Topics in Molecular and Structural Biology book series (TMSB)

Abstract

(+)-CC-1065 (Figure 4.1) was discovered in 1974 by scientists at The Upjohn Company in a fermentation screening program sponsored by the National Cancer Institute (Hanka et al. 1978). An X-ray structure of the drug was published in 1981 (Chidester et al., 1981) and the first detailed account of its interaction with DNA was published in 1982 (Li et al. 1982). (+)-CC-1065 is produced in fermentation broths of Streptomyces zelensis (Hanka et al. 1978), and although the biosynthetic precursors have been identified (Hurley and Rokem, 1983), the low antibiotic titre has hampered subsequent studies on its biosynthesis. At the time of isolation, (+)-CC-1065 was the most potent, small-molecular-weight compound known and showed cytotoxic potency and efficacy against a wide variety of tumours in vitro (Martin et al., 1981; Li et al., 1982). Unfortunately, the subsequent discovery of an unusual delayed lethality in mice at sub-therapeutic doses precluded (+)-CC-1065 from further development as a clinical agent (McGovren et al.1984). Subsequently, an aggressive and highly successful synthetic programme at The Upjohn Company has provided a series of three new compounds that appear to be more suitable for clinical development. These agents, Adozelesin, U-77779 and U-80244 (Figure 4.1), have been shown to have improved antitumour efficacy over (+)-CC-1065 and do not show delayed lethality (Warpehoski et al., 1988; Li et al. 1991).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abels, R. H. and Maycock, A. L. (1976). Acc. Chem. Res., 9, 313–319CrossRefGoogle Scholar
  2. Alberts, B. M. (1984). Cold Springs Harbor Symp. Biol., 49, 1–12CrossRefGoogle Scholar
  3. Bhuyan, B. K., Newell, K. A., Crampton, S. L. and Von Hoff, D. D. (1982). Cancer Res., 42, 3532–3537Google Scholar
  4. Boger, D. L. and Coleman, R. S. (1988). J. Org. Chem., 53, 695–698CrossRefGoogle Scholar
  5. Brown, W. C. and Romano, L. J. (1991). Biochemistry, 30, 1342–1350CrossRefGoogle Scholar
  6. Burkhoff, A. M. and Tullius, T. D. (1987). Cell, 48, 935–943CrossRefGoogle Scholar
  7. Chary, K. V. R., Hosur, R. V. and Govil, G. (1987). Biochemistry, 26, 1315CrossRefGoogle Scholar
  8. Chidester, C. G., Krueger, W. C., Mizasak, S. A., Duchamp, D. J. and Martin, D. B. (1981). J. Am. Chem. Soc., 103, 7629–7635CrossRefGoogle Scholar
  9. DeKoning, T. F., Kelly, R. C., Wallace, T. L. and Li, L. H. (1989). Proc. Am. Assoc. Cancer Res., 30, 491Google Scholar
  10. Dickerson, R. E., Kopka, M. L. and Pjura, P. E. (1987). In Guschlbauer, W. and Saenger, W. (eds), DNA-Ligand Interactions. From Drugs to Proteins. Plenum Press, New York, pp. 45–62Google Scholar
  11. Grootenhuis, P. D. J., Kollman, P. A., Seibel, G. L., Desjarlais, R. L. and Kuntz, I. D. (1990). Anti-Cancer Drug Design, 5, 237–242Google Scholar
  12. Hanka, L. J., Dietz, S. A., Gerpheide, S. A., Kuentzel, S. L. and Martin, D. G. (1978). J. Antibiot., 31, 1211–1217CrossRefGoogle Scholar
  13. Hanka, L. J., McGovren, J. P., Clarke, G. L., Pratt, E. A. and DeKoning, T. F. (1984). J. Antibiot., 37, 63–70CrossRefGoogle Scholar
  14. Haran, T. E. and Crothers, D. M. (1988). Biochemistry, 27, 6967–6971CrossRefGoogle Scholar
  15. Harbach, P. R., Trzos, R. J., Mazurek, J. H., Zimmer, D. M., Petzold, G. L. and Bhuyan, B. K. (1986). Cancer Res., 46, 406–410Google Scholar
  16. Hurley, L. H. (1989). J. Med. Chem., 32, 2027–2033CrossRefGoogle Scholar
  17. Hurley, L. H., Lee, C.-S., McGovren, J. P., Warpehoski, M. A., Mitchell, M. A., Kelly, R. C. and Aristoff, P. A. (1988). Biochemistry, 27, 3886–3892CrossRefGoogle Scholar
  18. Hurley, L. H. and Needham-VanDevanter, D. R. (1986). In Simic, M. G., Grossman, L. and Upton, A. D. (Eds), Mechanisms of DNA Damage and Repair. Plenum Press, New York, pp. 203–210CrossRefGoogle Scholar
  19. Hurley, L. H., Needham-VanDevanter, D. R. and Lee, C.-S. (1987). Proc. Natl Acad. Sci. USA, 84, 6412–6416CrossRefGoogle Scholar
  20. Hurley, L. H., Reynolds, V. L., Swenson, D. H., Petzold, G. L. and Scahill, T. A. (1984). Science, 226, 843–844CrossRefGoogle Scholar
  21. Hurley, L. H. and Rokem, J. S. (1983). J. Antibiot., 36, 383–390CrossRefGoogle Scholar
  22. Hurley, L. H., Warpehoski, M. A., Lee, C.-S., McGovren, J. P., Scahill, T. A., Kelly, R. C., Mitchell, M. A., Wicnienski, N. A., Gebhard, I., Johnson, P. D. and Bradford, V. S. (1990). J. Am. Chem. Soc., 112, 4633–4649CrossRefGoogle Scholar
  23. Husain, I., Abdel-Monem, M., Van Houten, B., Thomas, D. C. and Sancar, A. (1985). Proc. Nad Acad. Sci. USA, 82, 6774–6778CrossRefGoogle Scholar
  24. Ichimura, M., Ogawa, T., Takahashi, K., Kobayashi, E., Kawanoto, I., Yasuzawa, T., Takahashi, I. and Nakano, H. (1990). J. Antibiot., 43, 1037–1038CrossRefGoogle Scholar
  25. Jacobson, M. K., Twehous, D. and Hurley, L. H. (1986). Biochemistry, 25, 5929–5932CrossRefGoogle Scholar
  26. Katahira, M., Sugeta, H., Kyogoku, Y., Fujii, S., Fujisawa, R. and Tomita, K. (1988). Nucleic Acids Res., 16, 8619CrossRefGoogle Scholar
  27. Kohn, K. W., Hartley, J. A. and McHes, W. B. (1987). Nucleic Acids Res., 15, 10531–10544CrossRefGoogle Scholar
  28. Koo, H.-S. and Crothers, D. M. (1988). Proc. Natl Acad. Sci. USA, 85, 1763–1767CrossRefGoogle Scholar
  29. Koo, H.-S., Wu, H. M. and Crothers, D. M. (1986). Nature, 320, 501–506CrossRefGoogle Scholar
  30. Krueger, W. C., Duchamp, D. J., Li, L. H., Moscowitz, A., Petzold, G. L., Prairie, M. D. and Swenson, D. H. (1986). Chem. Biol. Interact., 59, 55–72CrossRefGoogle Scholar
  31. Krueger, W. C., Hatzenbuhler, N. T., Prairie, M. D. and Shea, M. H. (1991). Chem.-biol. Interact., 79 (3), 265–286CrossRefGoogle Scholar
  32. Krueger, W. C., Li, L. H., Moscowitz, A., Prairie, M. D., Petzold, G. L. and Swenson, D. H. (1985). Biopolymers, 24, 1549–1572CrossRefGoogle Scholar
  33. Krueger, W. C. and Prairie, M. D. (1987). Chem.-biol. Interact., 62, 281–295CrossRefGoogle Scholar
  34. Lee, E. H., Kornber, A., Hidaka, M., Kobayashi, T. and Horiuchi, T. (1989). Proc. Nad Acad. Sci. USA, 86, 9104–9108CrossRefGoogle Scholar
  35. Lee, C.-S., Sun, D., Kizu, R. and Hurley, L. H. (1991). Chem. Res. Toxicol., 4, 203–213CrossRefGoogle Scholar
  36. Lehman, I. R. (1974). Science, 186, 790–797CrossRefGoogle Scholar
  37. Li, L. H., Kelly R. C., Warpehoski, M. A., McGovren, J. P., Gebhard, I. and DeKoning, T. F. (1991). Invest. New Drugs, 9, 137–148CrossRefGoogle Scholar
  38. Li, L. H., Swenson, D. H., Schpok, S. L., Kuentzel, S. L., Dayton, B. D. and Krueger, W. C. (1982). Cancer Res., 42, 999–1004Google Scholar
  39. Li, L. H., Wallace, T. L., DeKoning, T. F., Warpehoski, M. A., Kelly, R. C., Prairie, M. D. and Krueger, W. C. (1987). Invest. New Drugs, 5, 329–337CrossRefGoogle Scholar
  40. Lin, C. H., Beale, J. M. and Hurley, L. H. (1991a). Biochemistry, 30, 3597–3602CrossRefGoogle Scholar
  41. Lin, C. H., Hill, G. C. and Hurley, L. H. (1992a). Chem. Res. Toxicol., 5, 167–182CrossRefGoogle Scholar
  42. Lin, C. H. and Hurley, L. H. (1990). Biochemistry, 29, 9503–9507CrossRefGoogle Scholar
  43. Lin, C. H., Sun, D. and Hurley, L. H. (1991b). Chem. Res. Toxicol., 4, 21–26CrossRefGoogle Scholar
  44. Lin, C. H., Yuan, Y.-C. and Hurley, L. H. (1992b). In preparationGoogle Scholar
  45. McAllister, C. F. and Achberger, E. C. (1989). J. Biol. Chem., 264, 10451–10456Google Scholar
  46. McGovren, J. P., Clarke, G. L., Pratt, E. A. and DeKoning, T. F. (1984). J. Antibiot., 37, 63–70CrossRefGoogle Scholar
  47. Martin, D. G., Biles, C., Gerpheide, S. A., Hanka, L. J., Krueger, W. C., McGovren, J. P., Miszak, S. A., Neil, G. L., Stewart, J. C. and Visser, J. (1981). J. Antibiot., 34, 1119–1125CrossRefGoogle Scholar
  48. Matson, S. (1986). J. Biol. Chem., 261, 10169–10175Google Scholar
  49. Moy, B. C., Prairie, M. D., Krueger, W. C. and Bhuyan, B. K. (1989). Cancer Res., 49, 1983–1988Google Scholar
  50. Needham-VanDevanter, D. R. and Hurley, L. H. (1986). Biochemistry, 25, 8430–8436CrossRefGoogle Scholar
  51. Pinto, A. L. and Lippard, S. J. (1985). Proc. Natl Acad. Sci. USA, 82, 4616–4619CrossRefGoogle Scholar
  52. Pitte, J. G. and Hearst, J. E. (1983). Proc. Natl Acad. Sci. USA, 80, 5540–5544CrossRefGoogle Scholar
  53. Reynolds, V. L., McGovren, J. P. and Hurley, L. H. (1986). J. Antibiot., 39, 319–334CrossRefGoogle Scholar
  54. Reynolds, V. L., Molineaux, I. J., Kaplan, D. J., Swenson, D. H. and Hurley, L. H. (1985). Biochemistry, 24, 6228–6237CrossRefGoogle Scholar
  55. Sancar, A. and Rupp, W. D. (1983). Cell, 33, 249–260CrossRefGoogle Scholar
  56. Sayer, J. M., Yagi, H., Croisy-Delcey, M. and Jerina, D. M. (1981). J. Am. Chem. Soc., 103, 4970–4972CrossRefGoogle Scholar
  57. Scahill, T. A., Jensen. R. M., Swenson, D. H., Hatzenbuhler, N. T., Petzold, G. L., Wierenga, W. and Brahme, N. D. (1990). Biochemistry, 29, 2852–2860CrossRefGoogle Scholar
  58. Selby, C. P. and Sancar, A. (1988). Biochemistry, 27, 7184–7188CrossRefGoogle Scholar
  59. Shore, D., Langowski, J. and Baldwin, R. (1981). Proc. Natl Acad. Sci. USA, 73, 4833–4837CrossRefGoogle Scholar
  60. Singer, B. and Grunberger, D. (1984). Molecular Biology of Mutagens and Carcinogens. Plenum Press, New YorkGoogle Scholar
  61. Sugiyama, H., Hosoda, M. and Saito, I. (1990). Tetrahedron Lett., 31, 1797–7200CrossRefGoogle Scholar
  62. Sun, D. and Hurley, L. H. (1992a). Biochemistry, 31, 2822–2829CrossRefGoogle Scholar
  63. Sun, D. and Hurley, L. H. (1992b). Anti-Cancer Drug Design, 7, 15–36Google Scholar
  64. Sun, D. and Hurley, L. H. (1992c). J. Med. Chem., 35, 1774–1782CrossRefGoogle Scholar
  65. Swenson, D. H., Li, L. H., Hurley, L. H., Rokem, J. S., Petzold, G. L., Dayton, B. D., Wallace, T. L., Lin, A. H. and Krueger, W. C. (1982). Cancer Res., 4, 2821–2828Google Scholar
  66. Tang, M.-S., Lee, C.-S., Doisy, R., Ross, L., Needham-VanDevanter, D. R. and Hurley, L. H. (1988). Biochemistry, 27, 893–901CrossRefGoogle Scholar
  67. Theriault, N. Y., Krueger, W. C. and Prairie, M. D. (1988). Chem.-biol. Interact., 65, 187–201CrossRefGoogle Scholar
  68. Ulanovsky, L., Bodner, M., Trifonove, E. N. and Choder, M. (1986). Proc. Natl Acad. Sci. USA, 83, 862–866CrossRefGoogle Scholar
  69. Warpehoski, M. A. (1986). Tetrahedron Leu., 27, 4103–4106CrossRefGoogle Scholar
  70. Warpehoski, M. A. (1991). Drugs of the Future, 16, 131–141Google Scholar
  71. Warpehoski, M. A. (1992). In Hurley, L. H. (Ed.), Advances in DNA Sequence Specific Agents. JAI Press, Greenwich, Vol. 1, 217–246Google Scholar
  72. Warpehoski, M. A. and Bradford, V. S. (1988). Tetrahedron Lett., 29, 131–134CrossRefGoogle Scholar
  73. Warpehoski, M. A., Gebhard, I., Kelly, R. C., Krueger, W. C., Li, L. H., McGovren, J. P., Prairie, M. D., Wicnienski, N. and Wierenga, W. (1988). J. Med. Chem., 31, 590–603CrossRefGoogle Scholar
  74. Warpehoski, M. A., Harper, D. E., Mitchell, M. A. and Monroe, T. J. (1992). Biochemistry, 31, 2502–2508CrossRefGoogle Scholar
  75. Warpehoski, M. A. and Hurley, L. H. (1988). Chem. Res. Toxicol., 1, 315–333CrossRefGoogle Scholar
  76. Zakrzewska, K. and Pullman, B. (1986). J. Biomol. Struct. Dynam., 4, 127–136CrossRefGoogle Scholar
  77. Zakrzewska, K., Randrianarivelo, M. and Pullman, B. (1987). Nucleic Acids Res., 15, 5775–5785CrossRefGoogle Scholar
  78. Zsido, T. J., Woynarowski, J. M., Baker, R. M., Gawron, L. S. and Beerman, T. A. (1991). Biochemistry, 30, 3733–3738CrossRefGoogle Scholar

Copyright information

© The contributors 1993

Authors and Affiliations

  • Laurence H. Hurley
  • Patricia H. Draves

There are no affiliations available

Personalised recommendations